Luoto, Kaisa E.
Lindholm, Lars H.
Paavonen, Vesa
Koivukangas, Antti
Lassila, Antero
Leinonen, Esa
Kampman, Olli
Funding for this research was provided by:
Seinäjoki Hospital District Research Fund
Article History
Received: 27 February 2018
Accepted: 17 July 2018
First Online: 27 July 2018
Ethics approval and consent to participate
: The study protocol was approved by the Seinäjoki Hospital District ethics committee (reference number EVO1114). Written informed consent was collected from all participants. At baseline, patients received written information and they had the option of asking for additional information during the study. Patients were informed that they could discontinue study participation at any time without dropping out of the treatment.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.